Augusto Sarralde-Delgado

Dr. Augusto Sarralde-Delgado


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jesús García-GómezJesús García-Gómez
Jesús García-Gómez
DRDALIA RAMIREZ
DALIA RAMIREZ
RPRosana Pelayo
Rosana Pelayo
OVOctavio Martínez Villegas
Octavio Martínez Villegas
LMLauro Fabian Amador Medina
Lauro Fabian Amador Medina
Adriana Aguilar-LemarroyAdriana Aguilar-Lemarroy
Adriana Aguilar-Lemarroy
Acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease where current clinical practice guidelines remain focused on traditional cytogenetic markers. Despite recent advances demonstrating excellent diagnostic accuracy for gene expression signatures, a discontinuity exists between biomarker validation and clinical implementation. This study aimed to develop and validate a multiparametric gene expression signature using digital PCR (dPCR) to accurately diagnose pediatric ALL, with potential utility for monitoring measurable residual disease (MRD). We analyzed 130 bone marrow aspirates from pediatric patients from four clinical groups: non-leukemia, MRD-negative, MRD-positive and leukemia characterized by immunophenotype. Gene expression of an 8-gene panel (JUP, MYC, NT5C3B, GATA3, PTK7, CNP, ICOSLG, and SNAI1) was quantified by dPCR. The diagnostic performance of individual markers was assessed, and a Random Forest machine learning model was trained to classify active disease. The model was validated using a 5-fold stratified cross-validation approach. Individual markers, particularly JUP, MYC, and NT5C3B, showed good diagnostic accuracy for distinguishing leukemia from non-leukemia. However, integrating all eight markers into a multivariate Random Forest model significantly enhanced performance. The model achieved a mean cross-validated area under the curve (AUC) of 0.908 (±0.041) on receiver operator characteristic (ROC) analysis and 0.961 (±0.019) on Precision–Recall (PR) analysis, demonstrating high reliability and a favorable balance between sensitivity and precision. The integrated model achieved high sensitivity (88.9%) for detecting active disease, particularly at initial diagnosis. Although specificity was moderate (65.0%), the high positive predictive value (PPV 85.1%) and accuracy (81.5%) confirm the clinical utility of a positive result. While the panel showed promising performance for distinguishing MRD-positive from MRD-negative samples, the limited MRD-positive cohort size (n = 11) indicates that validation in larger MRD-focused studies is required before clinical implementation for treatment monitoring. This dPCR-based platform provides accessible, quantitative detection without requiring knowledge of clonal shifts or specific genomic landscape, offering potential advantages for resource-limited settings such as those represented in our Mexican pediatric cohort.

24 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
CJCesar de Jesus Tovar Jacome
Cesar de Jesus Tovar Jacome
Luis Felipe Jave-SuárezLuis Felipe Jave-Suárez
Luis Felipe Jave-Suárez
Jesús García-GómezJesús García-Gómez
Jesús García-Gómez
Adriana Aguilar-LemarroyAdriana Aguilar-Lemarroy
Adriana Aguilar-Lemarroy
ASAugusto Sarralde-Delgado
Augusto Sarralde-Delgado
MRMonica Alejandra Rosales-Reynoso
Monica Alejandra Rosales-Reynoso
Background/Objectives: Colorectal cancer (CRC) is a leading cause of neoplasia-related morbidity and mortality worldwide and the first cause of cancer death in Mexico, where early detection remains a challenge, and reliable molecular biomarkers could support earlier diagnosis. Transcriptomic signatures for CRC have been published, but different studies arrive at gene lists that barely overlap, and since each study differs in both cohort and analysis, the source of that disagreement cannot be identified. This study aimed to identify a gene set for CRC discrimination whose selection depends neither on how the batch effect is handled nor on the criterion by which candidates are chosen and to validate that set in repositories that took no part in its selection. Methods: The signature was identified in 104 public RNA-seq samples (79 tumor, 25 reference) obtained from six BioProjects of the NCBI Sequence Read Archive and analyzed twice. A functionally anchored route took one representative gene per enriched biological program, ranked by π-value, from a differential expression model including BioProject as a covariate; a regularization route selected genes by their stability under Elastic Net in nested cross-validation over a ComBat-Seq-adjusted matrix. The genes reached by both routes were corroborated in TCGA-COAD, TCGA-READ, and GTEx colon processed by recount3 (n = 1542), with every parameter held fixed, and in the GEO microarray series GSE37364 (the 65 carcinoma and normal-mucosa samples of a 94-sample series), where only the coefficient vector was transferred because the platform differs; they were further examined descriptively in a second adenoma series (GSE89076), published stool RNA-seq, and plasma cell-free RNA. Results: The two routes yielded a seven-gene and a five-gene signature sharing a single gene, RPGRIP1L. Five genes met both criteria: TRIP13, CEMIP, PUS7, RPGRIP1L, and SLC22A3. With every parameter held fixed, the five-gene core reached an AUC of 0.9993 in TCGA/GTEx (sensitivity 0.966, specificity 0.998); with its coefficients transferred and the intercept recalibrated, it reached 0.9737 in GSE37364 (sensitivity 0.926, specificity 0.974). All five were elevated in adenoma relative to normal mucosa in GSE37364, and three of the five reached significance in GSE89076, where only five adenomas were available; all five were overexpressed in published stool RNA-seq of CRC patients. Conclusions: A five-gene core, TRIP13, CEMIP, PUS7, RPGRIP1L, and SLC22A3, discriminates colorectal tumor tissue from non-tumor in repositories external to its selection, with elevation already present in premalignant adenoma. Having been reached by two routes that share neither criterion nor starting point, these five genes are candidates for experimental validation and for evaluation in material accessible without biopsy.

23 August 2026 in Toxics
Verified
Journal Article
Open access
PDF file
Jesús García-GómezJesús García-Gómez
Jesús García-Gómez
OAOscar Humberto Rodríguez Aguirre
Oscar Humberto Rodríguez Aguirre
JRJorge Adrian Ruíz-Romero
Jorge Adrian Ruíz-Romero
ELElvia Harumi Scott Lopez
Elvia Harumi Scott Lopez
EBEric Becerra-Iñiguez
Eric Becerra-Iñiguez
Luis Felipe Jave-SuárezLuis Felipe Jave-Suárez
Luis Felipe Jave-Suárez
Lead is a neurotoxic metal. No safe blood lead level (BLL) has been identified in children; the CDC reference value was lowered to 3.5 µg/dL in 2021, while Mexico’s regulatory threshold remains at 10 µg/dL. Lead-glazed earthenware is the main documented source of pediatric exposure in Mexico. We studied children 0–15 years insured by the Mexican Social Security Institute (IMSS) in two Jalisco municipalities: Tonalá (n = 500), historically a ceramic-producing center, and Zapopan (n = 374), an urban area without this tradition. BLL was measured by graphite furnace atomic absorption spectrophotometry, and sociodemographic, environmental, occupational, and household exposure data were collected by questionnaire and analyzed with bivariate tests and multivariable models. Median BLL was 1.16 µg/dL in Tonalá and 2.08 µg/dL in Zapopan. Few children reached 5 µg/dL (3.2% and 6.4%), roughly twice as many exceeded 3.5 µg/dL (6.6% and 16.3%), and most exceeded 1 µg/dL (59.4% and 93.6%). In Zapopan, household glazed earthenware use and younger age were independently associated with a higher BLL in every model; in Tonalá, paternal professional occupation was associated with a lower BLL, an exploratory finding given its small subgroup. Widespread low-level exposure at both sites supports sustained facility-level surveillance and alignment of Mexico’s regulatory criterion with current reference values.